Evidence map›Paper›PMID 31341289›Full record

ArticleNature protocols2019

Creation of CRISPR-based germline-genome-engineered mice without ex vivo handling of zygotes by i-GONAD.

Channabasavaiah B Gurumurthy, Masahiro Sato, Ayaka Nakamura, Masafumi Inui, Natsuko Kawano, Md Atiqul Islam, Sanae Ogiwara, Shuji Takabayashi, Makoto Matsuyama, Shinichi Nakagawa and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature protocols, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 1 synthesis or guideline pooled it, 200 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A novel brachydactyly type E syndrome caused by variants in helix 8 of the PTH1R.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. TheeLife · 2025
    Article
  16. Article
  17. A simplified protocol for vitrification of hamster embryos.The Journal of reproduction and development · 2025
    Article
  18. Article
  19. ThebioRxiv : the preprint server for biology · 2025
    Article
  20. A mouse model of Jansen's metaphyseal chondrodysplasia for investigating disease mechanisms and candidate therapeutics.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Channabasavaiah B Gurumurthy *Mouse Genome Engineering Core Facility, Vice Chancellor for Research Office, University of Nebraska Medical Center, Omaha, NE, USA. cgurumurthy@unmc.edu.ORCID http://orcid.org/0000-0002-8022-4033
Masahiro Sato *Section of Gene Expression Regulation, Frontier Science Research Center, Kagoshima University, Kagoshima, Japan.
Ayaka NakamuraSupport Center for Medical Research and Education, Tokai University, Kanagawa, Japan.
Masafumi InuiLaboratory of Animal Regeneration Systemology, Department of Life Science, School of Agriculture, Meiji University, Kanagawa, Japan.ORCID http://orcid.org/0000-0003-4720-007X
Natsuko KawanoLaboratory of Regulatory Biology, Department of Life Science, School of Agriculture, Meiji University, Kanagawa, Japan.
Md Atiqul IslamDivision of Basic Medical Science and Molecular Medicine, School of Medicine, Tokai University, Kanagawa, Japan.
Sanae OgiwaraSupport Center for Medical Research and Education, Tokai University, Kanagawa, Japan.
Shuji TakabayashiLaboratory for Animal Resources Development, Hamamatsu University School Of Medicine, Hamamatsu, Shizuoka, Japan.
Makoto MatsuyamaDivision of Molecular Genetics, Shigei Medical Research Institute, Minami-ku, Okayama, Japan.
Shinichi NakagawaRNA Biology Laboratory, Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan.
Hiromi MiuraDivision of Basic Medical Science and Molecular Medicine, School of Medicine, Tokai University, Kanagawa, Japan.
Masato Ohtsuka *Division of Basic Medical Science and Molecular Medicine, School of Medicine, Tokai University, Kanagawa, Japan. masato@is.icc.u-tokai.ac.jp.ORCID http://orcid.org/0000-0002-6952-4238
Tokai University · JPMeiji University · JPHamamatsu University School of Medicine · JPHokkaido University · JPKagoshima University · JPNebraska Medical Center · USShigei Medical Research Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methods to create genetically engineered mice involve three major steps: harvesting embryos from one set of females, microinjection of reagents into embryos ex vivo and their surgical transfer to another set of females. Although tedious, these methods have been used for more than three decades to create mouse models. We recently developed a method named GONAD (genome editing via oviductal nucleic acids delivery), which bypasses these steps. GONAD involves injection of CRISPR components (Cas9 mRNA and guide RNA (gRNA)) into the oviducts of pregnant females 1.5 d post conception, followed by in vivo electroporation to deliver the components into the zygotes in situ. Using GONAD, we demonstrated that target genes can be disrupted and analyzed at different stages of mouse embryonic development. Subsequently, we developed improved GONAD (i-GONAD) by delivering CRISPR ribonucleoproteins (RNPs; Cas9 protein or Cpf1 protein and gRNA) into day-0.7 pregnant mice, which made it suitable for routine generation of knockout and large-deletion mouse models. i-GONAD can also generate knock-in models containing up to 1-kb inserts when single-stranded DNA (ssDNA) repair templates are supplied. i-GONAD offers other advantages: it does not require vasectomized males and pseudo-pregnant females, the females used for i-GONAD are not sacrificed and can be used for other experiments, it can be easily adopted in laboratories lacking sophisticated microinjection equipment, and can be implemented by researchers skilled in small-animal surgery but lacking embryo-handling skills. Here, we provide a step-by-step protocol for establishing the i-GONAD method. The protocol takes ∼6 weeks to generate the founder mice.

Indexed as

AnimalsCRISPR-Cas SystemsElectroporationFemaleGene EditingMaleMiceMicroinjectionsOviductsPregnancyRNA, Guide, CRISPR-Cas SystemsRNA, MessengerRNA, Guide, CRISPR-Cas SystemsRNA, Messenger

Identifiers

PMID31341289
OpenAlexW2964254127

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.